Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril for hospitalized patients with COVID-19 pneumonia
IRCT20140824018915N9Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of captopril in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Oxygen saturation rate, Length of hospitalization and 1 more. Started Jun 2021; status: completed.
02
Drugs
captopril
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20140824018915N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140824018915N9.